Business · 10/05/2011
National Institute of Allergy and Infectious Diseases Announces New Research Initiative to Combat COVID-19 Variants
The National Institute of Allergy and Infectious Diseases (NIAID) has launched a new research initiative to develop effective treatments and vaccines against emerging COVID-19 variants, building on its existing efforts to combat the pandemic.
Original source language: Federal Register — Health and Human ServicesOpen original release →